Gog 3007, a Randomized Phase Ii (Rp2) Trial of Everolimus and Letrozole (El) or Hormonal Therapy (Medroxyprogesterone Acetate/Tamoxifen, Pt) in Women with Advanced, Persistent or Recurrent Endometrial Carcinoma (Ec): A Gog Foundation Study